N06.21
Primary membranous nephropathy with isolated proteinuria
Clinical Classification Guidelines
Inclusion Terms
- Idiopathic membranous nephropathy (with isolated proteinuria)
- Primary membranous nephropathy, NOS
Excludes Type 1
- primary membranous nephropathy with nephrotic syndrome (N04.21)
Medical Intelligence & Overview
Primary membranous nephropathy with isolated proteinuria, classified under ICD-10 code N06.21, is a kidney condition characterized by the buildup of immune deposits in the membranes of the kidney's filtering units. This leads to excessive protein loss in the urine, a condition known as proteinuria. The term 'isolated' indicates that proteinuria is the main or only significant symptom, without apparent loss of kidney function or other symptoms initially. Often, this form of nephropathy is considered idiopathic, meaning its exact cause remains unknown.
Causes & Symptoms
Clinical Causes: Immune system abnormalities that cause immune deposits to form in the kidneys Genetic predispositions influencing immune responses or kidney structure Certain infections or diseases that may trigger immune reactions (though less common in idiopathic cases) Potential environmental factors, though no definitive links are established
Key Symptoms: Persistent protein in the urine (proteinuria), often detectable in urine tests Swelling or edema, particularly around the legs, ankles, or around the eyes, due to fluid retention Foamy or frothy urine resulting from high protein levels Sometimes, no noticeable symptoms in early stages; the condition may be identified through routine tests In some cases, increased blood pressure may be observed
Diagnostic & Treatment
Diagnosis Path: Diagnosing primary membranous nephropathy involves multiple steps: - **Urinalysis:** To detect and measure the amount of protein in urine - **Blood tests:** To assess kidney function and look for possible causes - **Kidney biopsy:** A tissue sample examined under a microscope to identify characteristic immune deposits in the kidney membranes - **Additional tests:** To rule out secondary causes, such as underlying autoimmune diseases or infections Since the condition is often idiopathic, tests focus on excluding other diseases and confirming the presence of characteristic immune deposits in the kidneys.
Treatment Protocols: Treatment approaches aim to reduce proteinuria, manage symptoms, and prevent kidney damage. They typically include: - **Medications:** - ACE inhibitors or angiotensin receptor blockers (ARBs) to lower proteinuria and control blood pressure - Immunosuppressive drugs in some cases, particularly if proteinuria persists or worsens - Diuretics to help reduce swelling - **Lifestyle modifications:** - Sodium restriction to decrease fluid retention - Maintaining a healthy weight and avoiding substances that may harm kidneys - **Monitoring:** Regular follow-up with health professionals to assess kidney function and evaluate treatment effectiveness In some cases, when significant kidney damage occurs, more advanced interventions like dialysis or transplant might be considered. It is important to tailor treatment to individual needs based on disease progression and response.
Clinical Advice & FAQs
Billing Guidance
Is N06.21 a billable ICD-10 code?
Yes, N06.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N06.21?
Clinical documentation must specify the nature of Primary membranous nephropathy with isolated proteinuria and any associated comorbidities for accurate reporting.
Cite this Clinical Reference